Molina Healthcare (NYSE:MOH) Price Target Lowered to $218.00 at Royal Bank Of Canada

Molina Healthcare (NYSE:MOH) had its price target cut by analysts at Royal Bank Of Canada from $248.00 to $218.00 in a report released on Friday,Benzinga reports. The firm currently has a “sector perform” rating on the stock. Royal Bank Of Canada’s target price points to a potential upside of 10.99% from the company’s current price.

Several other research firms have also issued reports on MOH. UBS Group raised their target price on shares of Molina Healthcare from $180.00 to $202.00 and gave the stock a “neutral” rating in a report on Friday, May 22nd. Weiss Ratings upgraded Molina Healthcare from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, June 25th. Truist Financial upped their target price on Molina Healthcare from $205.00 to $250.00 and gave the stock a “hold” rating in a research note on Tuesday, July 14th. Barclays cut their price target on shares of Molina Healthcare from $184.00 to $180.00 and set an “underweight” rating for the company in a report on Friday. Finally, Bank of America upgraded shares of Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 target price on the stock in a research report on Wednesday, April 29th. Three research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $204.94.

Molina Healthcare Price Performance

NYSE MOH traded down $3.88 during trading on Friday, hitting $196.41. 194,448 shares of the stock traded hands, compared to its average volume of 1,539,293. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.97. The company has a market capitalization of $10.23 billion, a P/E ratio of -1,092.85 and a beta of 0.74. Molina Healthcare has a 12-month low of $121.06 and a 12-month high of $244.89. The firm has a 50-day simple moving average of $205.93 and a 200-day simple moving average of $176.87.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings results on Wednesday, July 22nd. The company reported $1.51 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.12. The company had revenue of $10.87 billion for the quarter, compared to analysts’ expectations of $10.83 billion. Molina Healthcare had a negative net margin of 0.02% and a positive return on equity of 3.74%. Molina Healthcare’s quarterly revenue was down 4.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $5.48 earnings per share. As a group, analysts predict that Molina Healthcare will post 5.23 EPS for the current year.

Insider Buying and Selling

In other Molina Healthcare news, insider Jeff D. Barlow sold 17,811 shares of the business’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the transaction, the insider owned 67,175 shares of the company’s stock, valued at approximately $12,502,611. The trade was a 20.96% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CAO Maurice Hebert sold 600 shares of the stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $191.55, for a total transaction of $114,930.00. Following the completion of the sale, the chief accounting officer directly owned 12,815 shares of the company’s stock, valued at approximately $2,454,713.25. This trade represents a 4.47% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 1.44% of the company’s stock.

Institutional Trading of Molina Healthcare

Hedge funds and other institutional investors have recently bought and sold shares of the business. Torren Management LLC acquired a new position in Molina Healthcare in the fourth quarter valued at approximately $26,000. Physician Wealth Advisors Inc. lifted its stake in shares of Molina Healthcare by 1,250.0% in the first quarter. Physician Wealth Advisors Inc. now owns 216 shares of the company’s stock valued at $29,000 after purchasing an additional 200 shares during the period. Cromwell Holdings LLC boosted its holdings in Molina Healthcare by 211.9% during the fourth quarter. Cromwell Holdings LLC now owns 184 shares of the company’s stock worth $32,000 after buying an additional 125 shares in the last quarter. Quarry LP purchased a new position in Molina Healthcare in the fourth quarter valued at about $32,000. Finally, SJS Investment Consulting Inc. boosted its stake in shares of Molina Healthcare by 504.9% during the 1st quarter. SJS Investment Consulting Inc. now owns 248 shares of the company’s stock worth $33,000 after acquiring an additional 207 shares in the last quarter. 98.50% of the stock is currently owned by institutional investors and hedge funds.

Key Stories Impacting Molina Healthcare

Here are the key news stories impacting Molina Healthcare this week:

• Positive Sentiment: Molina beat Q2 adjusted EPS estimates, posting $1.51 per share versus expectations around $1.37-$1.39, and revenue also slightly topped forecasts at $10.87 billion. The company also raised its full-year earnings outlook, which suggests management still sees some profitability improvement ahead. Article Title
• Neutral Sentiment: Analysts maintained an overall “Hold” consensus on MOH, signaling that Wall Street sees limited near-term upside after the earnings report despite the beat. Article Title
• Neutral Sentiment: Conference call commentary highlighted solid Medicaid performance, helping offset some pressure in the broader results and giving investors more confidence that that segment is stabilizing. Article Title
• Negative Sentiment: Shares were pressured by weaker premium revenue, declining membership, and a higher medical care ratio, which pointed to margin strain and a drop in profitability versus last year. Article Title
• Negative Sentiment: Investors were also worried about Molina’s exchange/Obamacare business, with reports saying the company expects to cut its Obamacare presence roughly in half, adding to concerns about growth and enrollment trends. Article Title

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.